Delivery Order SPE2DB22D2005-SPE2DB26FJES1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Brilinta 90 mg tablets (60-count) with a ceiling value of $2,551.48. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by June 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Brilinta 60 mg tablets (60-count units) with a ceiling value of $4,769.52. This firm fixed price delivery order, with an ultimate completion date of July 21, 2025, represents a competitively awarded, non-set-aside contract utilizing AmerisourceBergen's existing pharmaceutical supply agreement. The order will be fulfilled from the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Brilinta 60 mg tablets in quantities of 60 units, with a contract ceiling value of $1,387.10. This competitively awarded, firm fixed-price delivery order is set to be completed by September 15, 2025, and represents fulfillment under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Brilinta 90 mg tablets (60-count packages) with a ceiling value of $3,983.15. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by October 31, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of BRILINTA 60 mg tablets (quantity 60s) with a ceiling value of $6,438.32. This firm fixed-price delivery order is scheduled for completion by September 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $11,180.17 to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count units) on October 22, 2025, with an ultimate completion date of October 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Brilinta 90 mg tablets (60-count) valued at $3,759.72, with an ultimate completion date of October 27, 2025. This competitively awarded, firm fixed-price delivery order was issued on October 24, 2025, with performance to be fulfilled at the vendor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting the open competition process...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of 60 tablets of BRILINTA 90 mg at a firm fixed price of $10,575.36. This non-set-aside, competitively awarded contract is scheduled for completion by September 22, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Brilinta 90mg tablets in quantities of 60 units, with a ceiling value of $1,830.38. This firm fixed price, competitively awarded delivery order is set to be completed by November 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Brilinta 90 mg tablets (60-count units) with a ceiling value of $10,703.47. This firm fixed-price delivery order is scheduled for completion by October 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was not designated as a set-aside contract, indicating it was competitively awarded among eligible...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB26FJES1Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on October 28, 2025, for the supply of Brilinta 60 mg tablets (60-count units) with a ceiling value of $2,473.64. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by October 29, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive pharmaceutical supply vehicle supporting military healthcare programs globally, enabling the company to deliver a wide range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal contract awards with DLA and other government healthcare systems, demonstrating its capability to fulfill federal medical procurement requirements consistently and competitively.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 10/28/25 |